Reduced lymph node yield in rectal carcinoma specimen after neoadjuvant radiochemotherapy
has no prognostic relevance.
Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy
. Part 2: diagnosis and management of mucositis.
Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy
in rectal cancer: preliminary results.
Per the study's protocol, newly diagnosed patients with advanced primary squamous cell carcinoma are treated with the Multikine treatment regimen for three weeks prior to receiving the Standard of Care, which involves surgery, radiation and/or concurrent radiochemotherapy
The primary objective of our Phase 3 study is to demonstrate that, by administering the Multikine treatment regimen prior to the current standard of care therapy, surgery followed by radiotherapy or followed by combined radiochemotherapy
, we can achieve a 10% increase in overall survival of the Multikine treated head and neck cancer patients.
Such a positive response was previously reported in a randomized clinical study in which advanced head and neck cancer patients received radiochemotherapy
and were analyzed for oral cavity toxicities (30).
There is a tendency of a potential benefit regarding radiotherapy or radiochemotherapy
in patients with resection margin positive tumors or even with unresectable tumors (16-18).
15-year survival rates after transurethral resection and radiochemotherapy
or radiation in bladder cancer treatment.
Complete resection of the tumor is still the best choice for patients with CPPs, considering the side effects of radiochemotherapy
. The findings of our study are consistent with those of previous reports.,,,,
In unresectable or resectable carcinomas of the head and neck, surgery and radiochemotherapy
are routinely performed; therefore, the use of enteral prophylactic approach, as jejunostomy, allows improving the quality of life of patients and prevents the complications of malnutrition during treatment.
Assessment of response to neoadjuvant radiochemotherapy
with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer.
Swallowing after non-surgical treatment (radiation therapy/ radiochemotherapy
protocol) of laryngeal cancer.